Antiproliferative Effect of 1α,25-dihydroxyvitamin D3 Involves Upregulation of Cyclin-Dependent Kinase Inhibitor p21 in Human Pancreatic Cancer Cells

被引:16
|
作者
Kanemaru, Mikio [1 ]
Maehara, Naoki [1 ]
Chijiiwa, Kazuo [1 ]
机构
[1] Miyazaki Univ, Sch Med, Dept Surg Oncol & Regulat Organ Funct, Kiyotake, Miyazaki 8891692, Japan
关键词
1; alpha; 25-dihydroxyvitamin D3; VDR; p21; Pancreatic cancer; Proliferation; VITAMIN-D ANALOGS; PROSTATE-CANCER; ELEVATED EXPRESSION; GEMCITABINE; D-3; MORTALITY; LINE; 1,25-DIHYDROXYVITAMIN-D3; DIFFERENTIATION; 1,25(OH)(2)D-3;
D O I
10.5754/hge11073
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: The aim of this study was to investigate the effect of 1 alpha,25-dihydroxyvitamin D3 on proliferation of human pancreatic cancer cell lines and to identify related cell cycle regulatory proteins with antiproliferative effects. Methodology: Human pancreatic cancer cell lines SUIT-2 and its four sublines, and Panc-1, AsPC-1, and MiaPaCa-2 were treated with1 alpha,25-dihydroxyvitamin D3. The number of cells was measured by the MTT method, and the cell cycle regulatory proteins were then analyzed by Western blotting. Results: Eight human pancreatic cancer cell lines expressed vitamin D receptor (VDR) mRNA. 1 alpha,25-dihydroxyvitamin D3 inhibited proliferation of SUIT-2 and its sublines. We found p21 to be upregulated after 24 hours in S2-028, the cell line in which proliferation was most inhibited by 1 alpha,25-dihydroxyvitamin D3. Conclusions: 1 alpha,25-dihydroxyvitamin D3 inhibited proliferation of pancreatic cancer cells and is involved in the upregulation of cyclin-dependent kinase inhibitor p21.
引用
收藏
页码:1199 / 1205
页数:7
相关论文
共 50 条
  • [41] 1α,25-dihydroxyvitamin D3 modulates the interaction between immune and colon cancer cells
    Bessler, Hanna
    Djaldetti, Meir
    BIOMEDICINE & PHARMACOTHERAPY, 2012, 66 (06) : 428 - 432
  • [42] Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21
    Musgrove, EA
    Lee, CSL
    Cornish, AL
    Swarbrick, A
    Sutherland, RL
    MOLECULAR ENDOCRINOLOGY, 1997, 11 (01) : 54 - 66
  • [43] p21(CIP1) and Cdc25A: Competition between an inhibitor and an activator of cyclin-dependent kinases
    Saha, P
    Eichbaum, Q
    Silberman, ED
    Mayer, BJ
    Dutta, A
    MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (08) : 4338 - 4345
  • [44] Anticoagulant effects of 1α,25-dihydroxyvitamin D3 on human myelogenous leukemia cells and monocytes
    Koyama, T
    Shibakura, M
    Ohsawa, M
    Kamiyama, R
    Hirosawa, S
    BLOOD, 1998, 92 (01) : 160 - 167
  • [45] Targeting 1α,25-dihydroxyvitamin D3 antiproliferative insensitivity in breast cancer cells by co-treatment with histone deacetylation inhibitors
    Banwell, CM
    O'Neill, LP
    Uskokovic, MR
    Campbell, MJ
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 89-90 (1-5): : 245 - 249
  • [46] 1α, 25-dihydroxyvitamin D3 induces α1-antitrypsin in human T cells, which is partially TGFβ-dependent
    Chen, Y. H.
    Rice, L. V.
    Mann, E. H.
    Dimeloe, S.
    Gooptu, B.
    Hawrylowicz, C. M.
    IMMUNOLOGY, 2014, 143 : 126 - 126
  • [47] Transcriptional regulation of cyclin-dependent kinase inhibitor 1A (P21) by the transcription factor AP-2γ
    Scibetta, A. G.
    Canosa, M.
    Hurst, H. C.
    BREAST CANCER RESEARCH, 2010, 12 : S7 - S7
  • [48] Transcriptional regulation of cyclin-dependent kinase inhibitor 1A (P21) by the transcription factor AP-2γ
    AG Scibetta
    M Canosa
    HC Hurst
    Breast Cancer Research, 12
  • [49] Effect of 1, 25-dihydroxyvitamin D3 on mast cells tryptase in asthmatic guinea pigs
    Zheng, Xiao-He
    Zhang, Gui-Dong
    Zhang, Guo-Hong
    Mai, Rui-Qin
    Shen, Ling
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2015, 8 (06) : 493 - 496
  • [50] IDENTIFICATION OF A PSTI POLYMORPHISM IN THE P21(CIP1/WAF1) CYCLIN-DEPENDENT KINASE INHIBITOR GENE
    LAW, JC
    DEKA, A
    HUMAN GENETICS, 1995, 95 (04) : 459 - 460